Search Within

Alexander Noor Shoushtari

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (22)
  2. Meeting Abstract (8)
  3. Research Letter (5)
  4. Review (2)
Groups
  1. Department of Medicine (37)
  2. Hematologic Malignancies, Division of (37)
  3. Melanoma Disease Management Team (37)
  4. Melanoma and Immunotherapeutics Service (37)
  5. Sloan Kettering Institute Postdocs (37)
  6. Solid Tumor Oncology Division (37)

More Groups

People
  1. Michael Postow (10)
  2. Marc Ladanyi (9)
  3. Nikolaus Schultz (8)
  4. David Solit (7)
  5. Jedd Wolchok (7)
  6. Michael Berger (7)

More People

Years
  1. 2024 (1)
  2. 2023 (4)
  3. 2022 (6)
  4. 2021 (10)
  5. 2020 (7)
  6. 2019 (3)

More Years

Publications
  1. Nature Genetics (3)
  2. Cancer Research (2)
  3. Clinical Cancer Research (2)
  4. Journal Der Deutschen Dermatologischen Gesellschaft (2)
  5. Journal of Clinical Oncology (2)
  6. Modern Pathology (2)

More Publications

Publishers
  1. Nature Publishing Group (8)
  2. American Association for Cancer Research (5)
  3. American Society of Clinical Oncology (3)
  4. Cell Press (2)
  5. Elsevier Inc. (2)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (37)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The association between tumor mutational burden and prognosis is dependent on treatment context
    Research Letter

    Valero, C.; Lee, M.; Hoen, D.; Wang, J.; Nadeem, Z.; Patel, N.; Postow, M. A.; Shoushtari, A. N.; Plitas, G.; Balachandran, V. P.; more...
    Nature Genetics (2021)

    Fulltext@MSK | Save
  • Tumor volume is a predictor of distant metastases and overall survival in sinonasal mucosal melanoma
    Meeting Abstract

    Flukes, S.; Lohia, S.; Barker, C. A.; Cracchiolo, J.; Ganly, I.; Patel, S.; Shah, J.; Shoushtari, A.; Tabar, V. S.; Shah, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Activating mutations in uveal melanoma convey sensitivity to g-alpha q inhibition
    Meeting Abstract

    Hitchman, T. D.; Ceraudo, E.; Moore, A. R.; Shoushtari, A. N.; Francis, J. H.; Guan, Y.; Chen, J.; Chang, M. T.; Taylor, B. S.; Sakmar, T. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Leveraging systematic functional analysis to benchmark an in silico framework distinguishes driver from passenger MEK mutants in cancer
    Journal Article

    Hanrahan, A. J.; Sylvester, B. E.; Chang, M. T.; Elzein, A.; Gao, J.; Han, W.; Liu, Y.; Xu, D.; Gao, S. P.; Gorelick, A. N.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma
    Journal Article

    Yang, C.; Sanchez-Vega, F.; Chang, J. C.; Chatila, W. K.; Shoushtari, A. N.; Ladanyi, M.; Travis, W. D.; Busam, K. J.; Rekhtman, N.
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Primary tumor volume as a predictor of distant metastases and survival in patients with sinonasal mucosal melanoma
    Journal Article

    Flukes, S.; Lohia, S.; Barker, C. A.; Cracchiolo, J. R.; Ganly, I.; Patel, S. G.; Roman, B. R.; Shah, J. P.; Shoushtari, A. N.; Tabar, V.; more...
    Head & Neck (2020)

    Fulltext@MSK | Save
  • UV genomic signature classifies lung melanomas of unknown primary as metastases from occult cutaneous melanomas
    Meeting Abstract

    Yang, C.; Sanchez-Vega, F.; Shoushtari, A.; Ladanyi, M.; Travis, W.; Busam, K.; Rekhtman, N.
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • Response to checkpoint blockade and survival in patients with stage III melanoma
    Meeting Abstract

    Theriot, J.; Bello, D.; Lobaugh, S.; Bartlett, E. K.; Betof, A.; Shoushtari, A.; Postow, M.; Callahan, M.; Brady, M. S.; Wong, R.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • MRI radiomic features are associated with survival in melanoma brain metastases treated with immune checkpoint inhibitors
    Journal Article

    Bhatia, A.; Birger, M.; Veeraraghavan, H.; Um, H.; Tixier, F.; McKenney, A. S.; Cugliari, M.; Caviasco, A.; Bialczak, A.; Malani, R.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • The impact of metastatic sites on checkpoint inhibitor outcomes in patients with cutaneous and unknown primary melanoma
    Meeting Abstract

    Krieger, P.; Sanchez-Vega, F.; Schultz, N.; Shoushtari, A.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save